Manhattan Scientifics, Inc. (MHTX)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Manhattan Scientifics Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.01M |
| December 31, 2022 | 0.011M |
| December 31, 2021 | 0.01M |
| December 31, 2020 | 0.011M |
| December 31, 2019 | 0.008M |
| December 31, 2018 | 0.052M |
| December 31, 2017 | 0.175M |
| December 31, 2016 | 3.335M |
| December 31, 2015 | 2.937M |
| December 31, 2014 | 1.861M |
| December 31, 2013 | 0.96M |
| December 31, 2012 | 0.274M |
| December 31, 2011 | 0.204M |
| Date | Value |
|---|---|
| December 31, 2010 | 0.028M |
| December 31, 2009 | 0.025M |
| December 31, 2008 | 0.198M |
| December 31, 2007 | 0.21M |
| December 31, 2006 | 0.221M |
| December 31, 2005 | 0.227M |
| December 31, 2004 | 0.125M |
| December 31, 2003 | 0.286M |
| December 31, 2002 | 0.865M |
| December 31, 2001 | 1.964M |
| December 31, 2000 | 3.093M |
| December 31, 1999 | 0.96M |
| December 31, 1998 | 0.663M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Tenax Therapeutics, Inc. | 32.67M |
| Exicure, Inc. | 3.286M |
| Century Therapeutics, Inc. | 82.57M |
| Absci Corp. | 80.72M |
| Celularity, Inc. | 9.222M |